Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor

PHASE4CompletedINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

February 27, 2023

Study Completion Date

February 27, 2023

Conditions

Preterm Labor

Interventions

DRUG

micronized progesterone 400 mg (Utrogestan)

participants receive vaginal micronized progesterone (Utrogestan- 200mg×2 PV(per vagina) per day)

Trial Locations (3)

Poriya Medical Center, Tiberias

Emek Medical center, Afula

Assuta Ashdod medical center, Ashdod

All Listed Sponsors

lead

HaEmek Medical Center, Israel

OTHER

NCT02430233 - Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor | Biotech Hunter | Biotech Hunter